A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
Condition(s):Renal Cell Carcinoma MetastaticLast Updated:December 12, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma MetastaticLast Updated:December 12, 2022Active, not recruiting
Condition(s):Renal Cell CarcinomaLast Updated:June 26, 2018Terminated
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:September 4, 2019Unknown status
Condition(s):Type B3 Thymoma; Thymic CarcinomaLast Updated:June 9, 2021Unknown status
Condition(s):Pancreatic Neuroendocrine Tumour MetastaticLast Updated:March 4, 2020Completed
Condition(s):Clear Cell Renal CarcinomaLast Updated:November 13, 2020Completed
Condition(s):Clear Cell, Metastatic Renal Cell CarcinomaLast Updated:March 6, 2018Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:January 12, 2023Terminated
Condition(s):Carcinoma, Renal CellLast Updated:December 17, 2020Completed
Condition(s):OsteosarcomaLast Updated:February 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.